Researches over the world have already proven that Ganoderma lucidum benefits poultry, cats and dogs a lot!
Pet Bird Love has adopted many dogs with health problems over the years. One of the dogs, Dandan, had caught the most severe and deadly type of tickborne protozoal blood parasite diseases that caused hemolytic anemia, thrombocytopenia, lethargy, and splenomegaly. Despite consulting a few veterinarians, all of them had no way to cure Dandan and suggested euthanasia. Our family did not want to give up and therefore we brought Dandan home and we treated him with Yunzhi and Ganoderma lucidum used by cancer patients. As a result, Dandan had lived for another 7 years! The case also received attention from many veterinarians who recommended the treatment to other sick dogs for reference. Since then, different Ganoderma products have appeared on the market one after another.
When animals get sick, they will gradually loss their appetite and finally give up eating at all. Ganoderma can enhance sick pet's appetite, boost their energy, at the same time repair liver, kidney, gastrointestinal organs etc, remove bad bacteria, and enhance immunity. Many foreign studies have already proven the efficacy of Ganoderma lucidum.
At Pet Bird Love, our Sky Blue Baby has kidney problem since childhood, and has been having watery poop for long. Sky Blue Baby has been relying on our own health care products all the years, and starting this year he has also taken Ganoderma lucidum. Thanks for God's blessings, he has been lovely and chubby for all these years despite his kidneys troubles.
Pet Bird Love has started incorporating the goodness of ganoderma into our products, enhancing our pets' body function and immunity, improving hair and allergy problems, and soothing the discomfort of them during sickness and treatment. Pet Bird Love strictly screen producers of Ganoderma and select only the one that brings the utmost purity and uses human-grade ingredients, to assure our pet’s wellness and provide the best food safety and efficiency.
Comments